VOLITIONRX LTD (VNRX) Fundamental Analysis & Valuation

NYSEARCA:VNRX • US9286611077

Current stock price

2.43 USD
-0.19 (-7.25%)
At close:
2.4903 USD
+0.06 (+2.48%)
After Hours:

This VNRX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. VNRX Profitability Analysis

1.1 Basic Checks

  • VNRX had negative earnings in the past year.
  • VNRX had a negative operating cash flow in the past year.
  • In the past 5 years VNRX always reported negative net income.
  • VNRX had a negative operating cash flow in each of the past 5 years.
VNRX Yearly Net Income VS EBIT VS OCF VS FCFVNRX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -10M -20M -30M

1.2 Ratios

  • VNRX has a Return On Assets of -338.45%. This is amonst the worse of the industry: VNRX underperforms 94.12% of its industry peers.
Industry RankSector Rank
ROA -338.45%
ROE N/A
ROIC N/A
ROA(3y)-250.57%
ROA(5y)-202.93%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
VNRX Yearly ROA, ROE, ROICVNRX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1K -1K -2K

1.3 Margins

  • VNRX does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
VNRX Yearly Profit, Operating, Gross MarginsVNRX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -50K -100K -150K -200K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. VNRX Health Analysis

2.1 Basic Checks

  • VNRX does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, VNRX has more shares outstanding
  • VNRX has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for VNRX is higher compared to a year ago.
VNRX Yearly Shares OutstandingVNRX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
VNRX Yearly Total Debt VS Total AssetsVNRX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M

2.2 Solvency

  • Based on the Altman-Z score of -57.16, we must say that VNRX is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -57.16, VNRX is doing worse than 94.65% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -57.16
ROIC/WACCN/A
WACC8.92%
VNRX Yearly LT Debt VS Equity VS FCFVNRX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M -10M 20M -20M -30M

2.3 Liquidity

  • A Current Ratio of 0.17 indicates that VNRX may have some problems paying its short term obligations.
  • The Current ratio of VNRX (0.17) is worse than 95.19% of its industry peers.
  • A Quick Ratio of 0.17 indicates that VNRX may have some problems paying its short term obligations.
  • VNRX's Quick ratio of 0.17 is on the low side compared to the rest of the industry. VNRX is outperformed by 95.19% of its industry peers.
Industry RankSector Rank
Current Ratio 0.17
Quick Ratio 0.17
VNRX Yearly Current Assets VS Current LiabilitesVNRX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. VNRX Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 28.39% over the past year.
  • The Revenue has grown by 40.04% in the past year. This is a very strong growth!
  • VNRX shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 180.21% yearly.
EPS 1Y (TTM)28.39%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%13.33%
Revenue 1Y (TTM)40.04%
Revenue growth 3Y77.29%
Revenue growth 5Y180.21%
Sales Q2Q%132.83%

3.2 Future

  • VNRX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 41.86% yearly.
  • The Revenue is expected to grow by 158.78% on average over the next years. This is a very strong growth
EPS Next Y56.81%
EPS Next 2Y68.14%
EPS Next 3Y53.16%
EPS Next 5Y41.86%
Revenue Next Year279.33%
Revenue Next 2Y500.01%
Revenue Next 3Y242.2%
Revenue Next 5Y158.79%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
VNRX Yearly Revenue VS EstimatesVNRX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 100M 200M 300M
VNRX Yearly EPS VS EstimatesVNRX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 0.5 -0.5 1

More info and screens

Find the best growth stocksShow best growing peers

1

4. VNRX Valuation Analysis

4.1 Price/Earnings Ratio

  • VNRX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year VNRX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
VNRX Price Earnings VS Forward Price EarningsVNRX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
VNRX Per share dataVNRX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.05 -0.1 -0.15 -0.2

4.3 Compensation for Growth

  • A more expensive valuation may be justified as VNRX's earnings are expected to grow with 53.16% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y68.14%
EPS Next 3Y53.16%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. VNRX Dividend Analysis

5.1 Amount

  • VNRX does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

VNRX Fundamentals: All Metrics, Ratios and Statistics

VOLITIONRX LTD

NYSEARCA:VNRX (5/1/2026, 8:04:00 PM)

After market: 2.4903 +0.06 (+2.48%)

2.43

-0.19 (-7.25%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Industry Strength16.77
Industry Growth32.3
Earnings (Last)03-31
Earnings (Next)05-13
Inst Owners13.01%
Inst Owner Change0.14%
Ins Owners6.89%
Ins Owner Change21.53%
Market Cap385.11M
Revenue(TTM)1.73M
Net Income(TTM)-23.36M
Analysts80
Price Target2.1 (-13.58%)
Short Float %5.29%
Short Ratio0.53
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-16.88%
Min EPS beat(2)-22.34%
Max EPS beat(2)-11.41%
EPS beat(4)0
Avg EPS beat(4)-20.53%
Min EPS beat(4)-30.72%
Max EPS beat(4)-11.41%
EPS beat(8)3
Avg EPS beat(8)-6.77%
EPS beat(12)5
Avg EPS beat(12)-3.02%
EPS beat(16)8
Avg EPS beat(16)-55.96%
Revenue beat(2)0
Avg Revenue beat(2)-53.06%
Min Revenue beat(2)-63.4%
Max Revenue beat(2)-42.72%
Revenue beat(4)1
Avg Revenue beat(4)-43.05%
Min Revenue beat(4)-71.37%
Max Revenue beat(4)5.28%
Revenue beat(8)1
Avg Revenue beat(8)-43.75%
Revenue beat(12)1
Avg Revenue beat(12)-44.74%
Revenue beat(16)1
Avg Revenue beat(16)-51.05%
PT rev (1m)-6.36%
PT rev (3m)-4.92%
EPS NQ rev (1m)0%
EPS NQ rev (3m)6.25%
EPS NY rev (1m)7.84%
EPS NY rev (3m)21.67%
Revenue NQ rev (1m)-44.87%
Revenue NQ rev (3m)-46.85%
Revenue NY rev (1m)-21.42%
Revenue NY rev (3m)-21.38%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 222.94
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.22
EYN/A
EPS(NY)-0.1
Fwd EYN/A
FCF(TTM)-0.12
FCFYN/A
OCF(TTM)-0.12
OCFYN/A
SpS0.01
BVpS-0.22
TBVpS-0.22
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -338.45%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-250.57%
ROA(5y)-202.93%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.25
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 9.11%
Cap/Sales 5.19%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.17
Quick Ratio 0.17
Altman-Z -57.16
F-Score3
WACC8.92%
ROIC/WACCN/A
Cap/Depr(3y)51.57%
Cap/Depr(5y)84.77%
Cap/Sales(3y)63.83%
Cap/Sales(5y)355.15%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)28.39%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%13.33%
EPS Next Y56.81%
EPS Next 2Y68.14%
EPS Next 3Y53.16%
EPS Next 5Y41.86%
Revenue 1Y (TTM)40.04%
Revenue growth 3Y77.29%
Revenue growth 5Y180.21%
Sales Q2Q%132.83%
Revenue Next Year279.33%
Revenue Next 2Y500.01%
Revenue Next 3Y242.2%
Revenue Next 5Y158.79%
EBIT growth 1Y19.56%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year57.3%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y25.29%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y23.98%
OCF growth 3YN/A
OCF growth 5YN/A

VOLITIONRX LTD / VNRX Fundamental Analysis FAQ

What is the ChartMill fundamental rating of VOLITIONRX LTD (VNRX) stock?

ChartMill assigns a fundamental rating of 2 / 10 to VNRX.


What is the valuation status of VOLITIONRX LTD (VNRX) stock?

ChartMill assigns a valuation rating of 1 / 10 to VOLITIONRX LTD (VNRX). This can be considered as Overvalued.


What is the profitability of VNRX stock?

VOLITIONRX LTD (VNRX) has a profitability rating of 0 / 10.


How financially healthy is VOLITIONRX LTD?

The financial health rating of VOLITIONRX LTD (VNRX) is 0 / 10.